Discontinued — last reported Q3 '23
Oracle Interest Paid remained flat by 0.0% to $843.50M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $913.75M to $843.50M. Over 3 years (FY 2022 to FY 2025), Interest Paid shows an upward trend with a 9.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $2.65B | $3.12B | $3.55B | $3.44B |
| YoY Change | — | +17.6% | +13.9% | -3.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.